Mielóma multiplex: vizsgálatok itt: Franciaország
91 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisFut, nem toborozA multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
- Where
- La Roche Sur Yon Cedex 9, Montpellier Cedex 5, Nantes, Nice, Poitiers, Tours
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to join2023-505775-70-00 - No phaseNot yet taking people in FranciaországProspective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
- Where
- Pierre-Bénite
- Életkor
- 18 év and over
- People
- 100
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07721350 - 1. fázisTaking peopleMYELOFLUDATEP: Exploratory study evaluating the value of 18F-Fludarabine PET for the initial or relapsed assessment and therapeutic evaluation of patients with symptomatic multiple myeloma.
- Where
- Angers, Brest, Caen Cedex 9, Nantes Cedex 1, Tours
- Életkor
- 18 év and over
- People
- 35
- Run by
- Centre Hospitalier Universitaire De Nantes
See details and how to join2024-515219-23-00 - 1/2. fázisNot yet taking people in FranciaországA Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Where
- Montpellier Cedex 5, Nantes, Paris, Poitiers, Toulouse
- Életkor
- 18 év and over
- People
- 88 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-525105-20-00 - 2. fázisTaking peopleIFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post transplantation maintenance therapy in patients with newly-diagnosed myeloma
- Where
- Amiens Cedex 1, Angers, Bayonne, Besancon Cedex, Caen Cedex 9, Clamart, Clermont-Ferrand, Compiegne, Créteil Cedex, Dijon, Epagny Metz-tessy, La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Libourne Cedex, Limoges, Lorient, Lyon, Marseille, Nantes, Nice, Nimes Cedex 9, Paris, Périgueux, Perpignan Cedex, Pessac Cedex, Poitiers, Quimper Cedex, Saint-Malo Cedex, Saint Nazaire Cedex, Strasbourg, Tarbes Cedex 9, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy Cedex, Vannes
- Életkor
- 18 év and over
- People
- 176
- Run by
- Centre Hospitalier Universitaire De Nantes
See details and how to join2024-517325-43-00 - 2. fázisTaking peopleA Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- Where
- Poitiers, Saint-Cloud
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06140524 · EU 2023-505242-25-00 - 4. fázisNot yet taking people in FranciaországElranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
- Where
- Paris, Paris Cedex 12, Pierre-Bénite
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Pfizer
See details and how to joinNCT06057402 · EU 2023-505200-33-00 - 1/2. fázisBefejeződöttStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Bordeaux, Villejuif
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - No phaseTaking peopleProspective Cohort With Hemopathy in Languedoc-Roussillon
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 500
- Run by
- University Hospital, Montpellier
See details and how to joinNCT02134574 - No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848 - No phaseTaking peoplePASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
- Where
- Épagny, Grenoble, Lyon, Montpellier, Saint-Etienne, Villefranche-sur-Saône
- Életkor
- 18 év to 70 év
- People
- 204
- Run by
- Centre Leon Berard
See details and how to joinNCT05947136 - No phaseTaking peopleDetermine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 300
- Run by
- University Hospital, Rouen
See details and how to joinNCT06559033 - 1. fázisTaking peopleStudy of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Lille Cedex, Marseille, Nice, Toulouse Cedex 9, Tours
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- AbbVie
See details and how to joinNCT06896916 · EU 2024-512146-41-00 - No phaseTaking peopleFollow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
- Where
- Toulouse
- Életkor
- 18 év and over
- People
- 2000
- Run by
- University Hospital, Toulouse
See details and how to joinNCT04888039 - No phaseTaking peopleBenefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma
- Where
- Annecy, Chambéry
- Életkor
- 61 év and over
- People
- 86
- Run by
- Centre Hospitalier Metropole Savoie
See details and how to joinNCT07547007 - 3. fázisFut, nem toborozA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Bobigny, Limoges Cedex 1, Nantes Cedex 2, Villejuif
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 2. fázisNot yet taking people in FranciaországA Phase 2, single arm Multicenter, Study testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
- Where
- Avignon Cedex 9, Bayonne, Creteil Cedex, La Roche Sur Yon Cedex 9, Lille Cedex, Montpellier Cedex 5, Nantes, Nantes Cedex 2, Paris, Pessac, Poitiers, Toulouse, Tours Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 70
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2025-521090-14-00 - 1. fázisTaking peopleStudy of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Where
- Lille, Nantes, Paris Cedex 12, Paris Cedex 13, Poitiers
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01 - 1. fázisTaking peopleA Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
- Where
- Lille, Nantes
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Sanofi
See details and how to joinNCT06630806 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Talence, Villejuif
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseNot yet taking people in FranciaországMultiple Myeloma Extramedulary Disease Samples FFPE
- Where
- Lyon 06
- Életkor
- 18 év and over
- People
- 15
- Run by
- BIWAKO
See details and how to joinNCT07354555 - No phaseNot yet taking people in FranciaországMultiple Myeloma t(4 ;14) FFPE Samples
- Where
- Lyon
- Életkor
- 18 év and over
- People
- 20
- Run by
- BIWAKO
See details and how to joinNCT07482761 - 1. fázisTaking peopleA Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Where
- Paris
- Életkor
- 18 év and over
- People
- 187 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06153251 · EU 2023-506003-26-00 - No phaseTaking peopleEvaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment
- Where
- Avignon
- Életkor
- 18 év and over
- People
- 120
- Run by
- Centre Hospitalier Henri Duffaut - Avignon
See details and how to joinNCT06789003 - No phaseTaking peopleReal-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Where
- Dijon, Nantes, Orléans, Pessac, Salouël
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Takeda
See details and how to joinNCT05879757